ʻO ka weheweheʻana
ʻO kā mākou Methyl 2-Methoxy-4-aminobenzoate i ke kī nui ma ka hanaʻana o ka lenvatinib, kahi i hoʻohanaʻia e mālama ai i ka maʻi yeron. Ua pāʻaniʻo kēia hui waena i kahi hana koʻikoʻi ma kaʻoihana lāʻau lapaʻau e like me ka mea maʻamau no ka synthesis o ka lenvatinib.
ʻO ka hoʻohui, kahi o kahi helu o 27492-84-84-8 Hoʻokeleʻia ka hoʻohanaʻana i kaʻenehana hou hou a me ka pākēnoʻiʻana i nā pāolaʻoi aku ka maikaʻi e hōʻoia i ka mea e hālāwai me ke kūlana o nā kūlana kiʻekiʻe. ʻO kā mākou lenvaninib kikowaena 2-Methoxy-4-Amanobenzoitic Acid Mathyl Ester i loaʻa i nā papaʻaina a he kūpono no ka hana nui.
ʻO kā mākou Miyyl 2-Methoxy-4-aminobenzeate keʻokeʻo e keʻokeʻo i ke aniani o ke aniani-keʻokeʻo keʻokeʻo He nui nā noi nui i loko o kaʻoihana lāʻau lapaʻau a kaulanaʻia no kona maʻemaʻe kūʻokoʻa a me ka kūpaʻa. Mālamaʻia ka hoʻohuiʻana o ka hoʻohuiʻana i kona kūlike i ka mālamaʻana a me ka hoʻounaʻana, eʻae ana i kā mākou mea kūʻai aku e hilinaʻi i kona mau mea kūʻai aku.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.
